Pfizer Inc -Expect Costs Associated With Multi-Year Cost Realignment Effort to Continue Through 2024 and to Total About $2.8 Bln
辉瑞公司——预计与多年成本调整工作相关的成本将持续到2024年,总额约为28亿美元
Pfizer Inc -Expect Costs Associated With Multi-Year Cost Realignment Effort to Continue Through 2024 and to Total About $2.8 Bln
辉瑞公司——预计与多年成本调整工作相关的成本将持续到2024年,总额约为28亿美元
使用浏览器的分享功能,分享给你的好友吧